Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study

Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-positive advanced GC (AGC). However, some patient...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Am J Cancer Res
Main Authors: Wang, Feng, Liu, Tian-Shu, Yuan, Xiang-Lin, Luo, Hui-Yan, Gu, Kang-Sheng, Yuan, Ying, Deng, Yan-Hong, Xu, Jian-Ming, Bai, Yu-Xian, Wang, Ying, Liao, Wang-Jun, Zhang, He-Long, Bi, Feng, Wang, Bang-Mao, Zhuang, Zhi-Xiang, Jiang, Teng-Jia, Xu, Rui-Hua
Format: Artigo
Sprog:Inglês
Udgivet: e-Century Publishing Corporation 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539783/
https://ncbi.nlm.nih.gov/pubmed/33042632
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker